Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)

NCT05567757 is registered in ClinicalTrials.gov with Vascudyne, Inc. as lead sponsor.

NCT NCT05567757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05567757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)
Lead sponsor
Vascudyne, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
October 4, 2022
Completion date
March 30, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease